Mutations that aberrantly activate trithorax-group proteins, Hox transcription factors and TALE-class Hox cofactors promote leukemogenesis, but their target genes critical for leukemogenesis remain largely unknown. Through genetic analyses in C. elegans, we find that the trithorax-group gene lin-59 and the TALEclass Hox cofactor unc-62 are required for survival of the VC motor neurons. With the goal of providing a model for how aberrantly active Hox complexes might promote leukemia, we elucidate the mechanism through which these new inhibitors of programmed cell death act: lin-59 maintains transcription of the Hox gene lin-39, while unc-62 promotes nuclear localization of the TALE-class Hox cofactor ceh-20. A LIN-39/ CEH-20 complex binds the promoter of the pro-apoptotic BH3-only gene egl-1, repressing its transcription and ensuring survival of the VC neurons. In the absence of this regulatory mechanism, egl-1 is transcribed and the VC neurons die. Furthermore, ectopic expression of the Hox gene lin-39, as occurs for human Hox genes in leukemia, is sufficient to block death of some cells. This work identifies BH3-only pro-apoptotic genes as targets of Hox-mediated repression and suggests that aberrant activation of Hox networks may promote leukemia in part by inhibiting apoptosis.
Introduction
Programmed cell death, or apoptosis, is an evolutionarily conserved mechanism for safely removing unneeded or damaged cells from an organism. The genetic basis for programmed cell death was first discovered in the nematode Caenorhabditis elegans (Ellis and Horvitz, 1986) , and the detailed description of a genetic pathway for programmed cell death in this organism provided an essential foundation for understanding the very similar but more complex pathways of mammals (Danial and Korsmeyer, 2004) . A core pathway of four genes executes apoptosis in C. elegans (Metzstein et al., 1998) . The Bcl-2 homolog CED-9 promotes cell survival by inhibiting the Apaf-1 homolog CED-4 (Hengartner et al., 1992; Hengartner and Horvitz, 1994; Spector et al., 1997) . Apoptosis is initiated in many cells when the BH3-only protein EGL-1 relieves this inhibition, allowing CED-4/Apaf-1 to activate the caspase CED-3, which kills the cell (Conradt and Horvitz, 1998; Shaham and Horvitz, 1996; Wu et al., 1997) . (To aid readers, we identify C. elegans genes and proteins by their name followed by the name of the homologous mammalian molecule or family.)
Comparatively much less is known about how individual cells of C. elegans decide whether to survive or undergo programmed cell death, although it is clear that direct transcriptional regulation of core pathway genes has a central role (Conradt and Horvitz, 1999; Liu et al., 2006; Maurer et al., 2007; Metzstein et al., 1996; Metzstein and Horvitz, 1999; Park et al., 2006; Thellmann et al., 2003) . Because C. elegans develops in an essentially invariant pattern, it has been possible to identify and study pathways that regulate the survival or death of individual cells. In at least one case, a pathway that regulates cell death and survival in specific cells of C. elegans is evolutionarily conserved and important for the survival of human cancer cells (Inaba et al., 1996 (Inaba et al., , 1992 Inukai et al., 1999) . This is consistent with cancer cells ensuring their survival by co-opting developmental pathways that normally regulate programmed cell death.
Gain-of-function mutations affecting Hox gene function are among the most common mutations identified in human leukemias. Most notably, chromosomal translocations that aberrantly activate the Trithorax homolog MLL are common in particularly aggressive forms of acute lymphoblastic and acute myeloid leukemia (Grimwade et al., 1998; Pui et al., 2004) , and increased activity of particular Hox genes mediate important aspects of MLL action in humans and in mouse models (Armstrong et al., 2002; Drabkin et al., 2002; Ferrando et al., 2003; Krivtsov et al., 2006; Rozovskaia et al., 2003; Somervaille and Cleary, 2006; Yeoh et al., 2002) . Despite intensive study of the critical roles of Hox proteins, cofactors, and their regulators in leukemogenesis, the biologically relevant target genes regulated by Hox proteins that contribute to the malignant phenotype remain largely unknown. Acute inhibition of HoxA9 in MLL-rearranged leukemia induces apoptosis, indicating that one role of Hox overexpression in this leukemia is to prevent cell death (Faber et al., in press) ; the mechanism through which HoxA9 ensures cell survival in this setting is unknown. We have previously reported direct transcriptional regulation of egl-1/ BH3 and programmed cell death by a Hox protein complex in C. elegans (Liu et al., 2006) . In this case, the Hox protein MAB-5 and the TALEclass Hox cofactor CEH-20 bind directly to a regulatory element of egl-1/BH3 to induce egl-1 transcription and programmed cell death. This suggests that cell death genes could represent Hox targets critical for leukemogenesis. However, in this example from C. elegans and a similar example in Drosophila (Lohmann et al., 2002) , cell death is initiated by Hox activity; suppression of programmed cell death would be more consistent with promoting cancer. We therefore investigated the mechanism through which the Hox protein LIN-39 ensures survival of specific cells of C. elegans (Clark et al., 1993) with the goal of presenting a model for how abnormally active Hox activity might promote cancer.
In this study, we identify two new repressors of programmed cell death that further extend the correlation between genes that regulate death in C. elegans and human counterparts that are oncogenes. We identify lin-59/Ash1 (a trithorax-like gene), and unc-62/Meis (a TALEclass Hox cofactor) as being essential for preventing programmed cell death of specific cells in the developing ventral nerve cord, and elucidate the mechanism through which they ensure cell survival. Our findings suggest that developmental regulation of programmed cell death includes direct transcriptional repression of pro-apoptotic BH3-only genes, and that overexpressed or ectopically expressed Hox proteins may co-opt the mechanism described here to promote oncogenesis.
Materials and methods

Genetics and lineage analysis
All strains were derived from Bristol N2 wild-type and cultured as described (Brenner, 1974) . Alleles used in this study included: LGI: lin-59(n3168); lin-59(n3192); ced-1(e1735).
LGII: rrf-3(pk1426).
LGIII: ceh-20(ay9); ceh-20(ay42); lin-39(n1760); unc-36(e251).
LGIV: ced-3 (n717).
LGV: unc-62(e644); unc-62(e917); unc-62(t2012); dpy-11 (e224); egl-1(n1084n3082).
LGX: lin-15(n765); mxIs14, an integrated P egl-1 histone:gfp transgene (Liu et al., 2006) ; mxIs28, an integrated P ceh-20 ceh-20:yfp transgene; mxIs31, an integrated P unc-62 unc-62:cfp transgene. deIs1 is an integrated, unmapped YAC-based P lin-39 lin-39: gfp transgene (Wagmaister et al., 2006) . Lineage analysis was performed as described previously (Sulston and Horvitz, 1977) .
lin-59 alleles
Two partial loss-of-function alleles of lin-59 were identified in a screen of mutagenized ced-1 mutants (Cameron et al, 2002) . We used the rectal patterning defect of n3168 mutants to identify n3168 homozygotes, and found that 28 of 36 n3168 progeny of ced-1 n3168/++ animals were Ced, suggesting linkage to LGI. From n3168++/+dpy-5 unc-29 heterozygotes, 18 of 18 Unc-29 non-Dpy-5 recombinants carried n3168. Zero of 24 Unc-11 non-Dpy-5 recombinants from n3168++/+unc-11 dpy-5 heterozygotes carried n3168. 12 of 12 Lin-17 non-Unc-11 recombinants from +n3168+unc-29/lin-17+unc-11+ heterozygotes carried n3168. In crosses of qDf3 and qDf4 males into n3168 unc-29 hermaphrodites, we failed to obtain identifiable non-Unc-29 cross progeny, suggesting that qDf3 and qDf4 delete n3168, that n3168/Df animals die, and that the n3168 mutation results in a partial loss of lin-59 function. In all cases, the ventral nerve cord cell corpse phenotype and rectal defect cosegregated. Sequencing of lin-59 genomic DNA identified point mutations consistent with EMS-induced changes that result in an R844Opal mutation (in n3168) and a G616Amber mutation (in n3192).
RNAi and imaging
The screen for regulators of egl-1 expression was performed by RNAi feeding of ced-1(e1735); ced-3(n717); mxIs14 or rrf-3(pk1426); ced-3(n717); mxIs14 mutants, as described (Fraser et al., 2000) . L3-stage progeny were observed using epifluorescence and photographed by subtracting the rhodamine filter (emission 610-675) image from the FITC band-pass filter image to reduce background fluorescence.
Reporter constructs
Reporter constructs were made using standard cloning techniques, introduced into worms using microinjection, and integrated using gamma irradiation. P ceh-20 ceh-20:yfp was constructed identically to P ceh-20 ceh-20:cfp (Liu et al., 2006) , except that yfp from pPD134.99 (a kind gift from Andy Fire, Stanford University, Palo Alto, CA, USA) was cloned into the AscI restriction site. This construct rescued the Egl phenotype of ceh-20(ay42) mutants (data not shown). It was injected into ced-1; ced-3; lin-15 mutants at 50 ng/μL along with a lin-15 rescuing plasmid (50 ng/μL), integrated using gamma irradiation, and back-crossed to N2 nine times. P unc-62 unc-62:cfp was constructed from the cosmid T28F12 and the fosmid WRM061dC01 in several steps. First, a 20 kb PmeI-SacII fragment from WRM061dC01 was inserted into pBSKSII+ digested with SacII and SmaI (pMP040). Separately, a 12 kb SacII fragment from T28F12 was ligated into the SacII site of pBSKSII+ (pMP041). A 2 kb fragment of pMP041 containing the stop codon of unc-62 was PCR-amplified and cloned into pBSKSII+ (pMP042), and the stop codon was replaced with an AgeI restriction site using site-directed mutagenesis (pMP043). The coding region of cfp was PCR-amplified from pPD134.96 (a kind gift from Andy Fire) and inserted into the AgeI site of pMP043 to produce pMP044. The NheI-PacI fragment of pMP041 containing the unc-62 termination codon was replaced with the 3 kb NheI-PacI fragment of pMP044, essentially creating the unc-62:cfp fusion (pMP046). Finally, the 13 kb SacII fragment from pMP046 was inserted into the SacII site of pMP042 to produce the final P unc-62 unc-62:cfp plasmid, pMP062. This construct contains 32 kb of the unc-62 genomic locus (including the coding region, 14 kb of upstream sequence, and 4 kb of downstream sequence) with a C-terminal cfp fusion, in the pBSKSII+ backbone. pMP062 was injected at 10 ng/μL into lin-15(n765mat,ts) mutants with a rescuing lin-15 construct at 50 ng/μL, and integrated using gamma irradiation. The resulting animals were back-crossed to N2 six times. All DNA fragments subjected to PCR amplification were completely sequenced.
Protein purification and EMSA
Amino acids 141-229 of LIN-39 and 188-274 of CEH-20 were purified from E. coli using the IMPACT ™ Protein Purification Kit (New England Biolabs, Ipswich, MA, USA). EMSA binding reactions to a biotinylated consensus Hox-Pbx probe (Liu and Fire, 2000) were performed at room temperature for 30 min. in 1× TBB (10 mM Tris pH 7.5, 1 mM EDTA, 1 mM DTT, 0.1% NP-40, 5% glycerol), 500 ng poly dIdC, 200 ng LIN-39 where included, 400 or 800 ng CEH-20 where included, 20 fmol biotinylated Antp/Exd probe (Liu and Fire, 2000) , and water to 25 μL. The reactions were run on an 8% polyacrylamide native gel in 0.5× TBE (45 mM Tris-borate, 1 mM EDTA) at 4°C and transferred to a nylon membrane that was developed using the LightShift ® Chemiluminescent EMSA Kit (Pierce, Rockford, IL, USA).
LIN-39 rescue assay
P egl-1 lin-39 constructs were assembled by precisely replacing the histone:gfp insert of pMP001 (P egl-1 histone:gfp) (Liu et al., 2006) with lin-39 cDNA. Site-directed mutagenesis was used to mutate W151 to F or WM to AA. The repression domain of Engrailed (corresponding to amino acids 1-298 of D. melanogaster protein) or the activation domain of VP16 (corresponding to amino acids 413-490 of HSV-1 protein) was PCR-amplified with primers containing AgeI (5′) and PacI (3′) sites, lin-39 cDNA was amplified with primers containing PacI (3′) and AgeI (3′) sites, and a triple ligation was used to introduce these fragments into the AgeI-digested pMP001. All constructs were fully sequenced. These were injected into ced-1(e1735); lin-39(n1760) animals at 50 ng/μL along with P myo-3 gfp (50 ng/μL) as a coinjection marker. Transgenic lines were identified by GFP fluorescence, and at least three independent lines per construct were scored for corpse pattern in the ventral nerve cord. We were unable to perform similar rescue experiments with ceh-20/Pbx and unc-62/Meis mutants because of the lethality associated with loss-of-function of either gene, as has been previously observed when attempting to construct transgenic animals with these mutants (Van Auken et al., 2002) .
Chromatin immunoprecipitation
Chromatin immunoprecipitations were performed using the anti-AFP antibody (Qbiogene, Carlsbad, CA, USA) and quantified using realtime PCR.
Chromatin preparation
Mixed stage P lin-39 lin-39:gfp, P ceh20 ceh20:yfp and P unc62 unc62:cfp animals were grown at 22.5°C, harvested and flash frozen with liquid nitrogen. 600 μL of frozen worms was subsequently ground into fine powder with a mortar and pestle. The powder was washed once with 4 mL of ice-cold M9 buffer. 4 mL of 1% formaldehyde in M9 was used for a 10 minute fixation at room temperature, and then the reaction was quenched for 5 min with 1.714 mL of 1 M glycine. After 10 min on ice, the extract was washed once with 4 mL of ice-cold M9 buffer and twice with 4 mL of ice-cold FA Buffer (50 mM HEPES/KOH pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X100, 0.1% Sodium deoxycholate). The extract was resuspended to 1.5 mL with ice-cold FA Buffer plus 64 μL of 25× protease inhibitor cocktail (Roche, Tucson, AZ, USA) and sheared to 100 bp 1000 bp size range with an Ultrasonic Processor sonicator. An output of 8 W was used for sonication (ten cycles of 30 s pulses followed by 2.5 min breaks in ice water). Cellular debris was removed by centrifugation at 14,000 rpm for 30 min at 4°C, and the supernatant was frozen at − 80°C.
Immunoprecipitation
1 μg of anti-AFP antibody (Qbiogene, Carlsbad, CA, USA) or 1 μg of mouse IgG (Innovative Research, Novi, MI, USA) and 25 μL of protein A Sepharose beads (Carlsbad, CA, USA) were incubated in 275 μL of FA Buffer for 2 h rotating at 4°C. These beads were then washed with FA Buffer three times and blocked with herring sperm DNA (200 μg/mL) and BSA (0.1 mg/mL) in FA Buffer for 2 h rotating at 4°C. The beads were washed with FA Buffer three times. The chromatin was diluted in 6 mL of FA Buffer containing 1× protease inhibitor cocktail and precleared with 200 μL of 50% protein A Sepharose beads in FA Buffer rotating at 4°C for 2 h. The pre-cleared chromatin was centrifuged at 2000 rpm at 4°C for 5 min. 10% of the supernatant was saved as input, and the remaining material was divided into two equal volumes. IgGbound beads were added to one fraction of chromatin while anti-AFPbound beads were added to the other fraction, and both were incubated overnight rotating at 4°C.
DNA recovery
The beads were centrifuged at 2000 rpm at 4°C for 5 min and then sequentially washed at 4°C with 1 mL of the following buffers: FA Buffer with 0.1% SDS (5 min, 2×), FA Buffer with 1 M NaCl (5 min), FA Buffer with 500 mM NaCl (10 min), TEL Buffer (0.25 M LiCl, 1% NP40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl pH 8.0) (10 min), and TE pH 8.0 (10 mM Tris pH 8.0, 1 mM EDTA) (5 min, 2×). Complexes were eluted from the beads with 100 μL Elution Buffer (50 mM Tris-HCl pH 7.5, 10 mM EDTA, 1% SDS) at 65°C for 10 min. After centrifugation at 2000 rpm at room temperature for 5 min, the supernatant was added to 80 μL TE pH 7.5 and 20 μL proteinase K (20 mg/mL). Cross-linked polypeptides were digested at 42°C for 2 h, and cross-links were reversed overnight at 65°C. 20 μL of 4 M LiCl was added and the DNA was purified by phenol/chloroform extraction. The DNA was dissolved in 35 μL of water and 2 μL was used for each quantitative PCR reaction.
RNA extraction and quantitative PCR
RNA was extracted from mixed-stage worms using TRIzol ® Reagent, treated with DNase I (Invitrogen, Carlsbad, CA, USA) and converted to cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). An amount of cDNA corresponding to 50 ng of input RNA was used for each quantitative PCR reaction. Quantitative PCR was performed using the delta-delta Ct method with Power SYBR ® Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) on a 7900HT Fast Real-Time PCR System (Applied Biosystems) according to the manufacturer's instructions.
Results
The trithorax-group gene lin-59/Ash1 is required for survival of the VC motor neurons
Hox transcription is controlled by many factors including the opposing activities of polycomb-and trithorax-group genes, which generally maintain the repressed and activated states of transcription, respectively (Schuettengruber et al., 2007) . In a screen for genes that Table 1 Hox and Hox cofactor genes are required for cell survival and repression of egl-1/BH3 transcription in the midbody. 2.8 ± 0.2 5.7 ± 0.1 4.3 ± 0.1 unc-62/Meis(e644)
2.6 ± 0.2 0.2 ± 0.1 6.6 ± 0.1 unc-62/Meis(e917) 4.5 ± 0.3 1.3 ± 0.2 6.7 ± 0.2 unc-62/Meis(t2012) b 1.9 ± 0.2 0.7 ± 0.1 4.4 ± 0.2 (A) Number of corpses; mean ± s.e.m. All strains were homozygous for ced-1(e1735).
The allele of egl-1 used was n1084n3082. n = 18 for lin-59(RNAi), n = 30 for all others.
(B) Numbers of nuclei expressing P egl-1 gfp; mean ± s.e.m. Complete genotypes were as indicated plus ced-3(n717); P egl-1 gfp. Rows one to five also included ced-1(e1735), row seven included unc-36(e251), and row ten included dpy-11(e224). Animals were scored as L3 larvae. n = 30 for unc-22(RNAi); n = 50 for all others. a The anterior ventral nerve cord includes the retrovesicular ganglion, in which some cells die embryonically (Sulston et al., 1983) . The persistence of corpses in this region through to the L3 larval stage is variable. b Animals of this genotype exhibited extremely abnormal and variable body morphology; as a result, nuclei numbers may be artificially low because the ventral nerve cord was difficult to identify.
regulate programmed cell death in the ventral nerve cord (Cameron et al., 2002) , we identified two alleles of the trithorax-group gene lin-59, which encodes a SET domain-containing protein homologous to the Drosophila Ash1 and human Ash1L histone methyltransferases (Chamberlin and Thomas, 2000) . lin-59(n3192) and lin-59(n3168) encode premature stop codons that are predicted to truncate the protein just N-terminal and just C-terminal to the SET domain, respectively (Supplemental Fig. 1 ). Genetic analyses suggest that both alleles result in partial loss of gene function (see Materials and methods).
To study the effect of lin-59/Ash1 loss on the pattern of programmed cell deaths, we used ced-1(e1735) mutants in which most dying cells persist as visible corpses. In an otherwise wild-type ced-1 background, corpses are visible in the anterior and posterior regions of the ventral cord where cell deaths occur, but never in the midbody region where all cells survive (Sulston, 1976) . Whereas control unc-22(RNAi) does not alter this wild-type pattern, lin-59/ Ash1 mutants and lin-59/Ash1(RNAi) animals exhibit cell corpses in the midbody region of the ventral nerve (Table 1A) . Analysis of cell lineages of the P3-P8 blast cells in four lin-59(n3168) animals confirmed programmed cell death of the VC neurons (Figs. 1A, B) . Thus survival of the VC neurons requires lin-59/Ash1. lin-59/Ash1 promotes transcription of lin-39/Hox lin-59/Ash1 regulates expression of the posterior Hox genes mab-5 and egl-5 (Chamberlin and Thomas, 2000) . We therefore investigated whether lin-59/Ash1 promotes VC neuron survival by maintaining transcription of the midbody Hox gene lin-39, which ensures survival of the VC neurons through unknown mechanisms (Table 1A) (Clark et al., 1993) . Because the P lin-39 gfp reporter is extremely dim even in wild-type animals, we used quantitative PCR to compare lin-39/Hox transcript levels in the presence and absence of lin-59. We found decreased lin-39/Hox mRNA in lin-59(RNAi), lin-59(n3168) and lin-59 (n3192) mutants compared to wild-type animals (Figs. 1C, D) . mRNA levels of the Hox cofactor ceh-20/Pbx and two controls were normal in lin-59/Ash1 mutants (Fig. 1E ). These data suggest that lin-59/Ash1 promotes VC survival by maintaining mRNA levels of lin-39/Hox. unc-62/Meis represses egl-1/BH3 transcription To discover additional genes that regulate VC survival we used a gfp reporter of egl-1/BH3 transcription and RNAi of candidate genes to identify genes that contribute to the normal pattern of programmed cell death in the ventral nerve cord. The BH3-only gene egl-1 is required for programmed cell death of somatic cells of C. elegans and is transcriptionally regulated to control the survival or death of specific cells Horvitz, 1998, 1999; Liu et al., 2006; Thellmann et al., 2003) . We developed a transcriptional reporter of egl-1/BH3 by integrating a P egl-1 histone:gfp transgenic construct, in which the open reading frame of egl-1/BH3 is precisely replaced with sequences encoding a histone:gfp fusion (see Materials and methods), into ced-3/caspase mutants (Liu et al., 2006) . In this strain, which we refer to as P egl-1 gfp, the ced-3/caspase mutation prevents cell death, and a histone:gfp fusion gene is expressed under control of the egl-1/ BH3 regulatory region.
In P egl-1 gfp hermaphrodites the pattern of GFP expression precisely matched the pattern of programmed cell deaths in the midbody and posterior regions of the ventral nerve cord (shown schematically in Fig. 2A) . Specifically, all cells that undergo programmed cell death in wild-type animals expressed GFP, and all cells that survive in wildtype animals did not (data not shown). This suggests that the pattern of programmed cell death and survival in these regions is largely determined by controlling transcription of egl-1/BH3, and that the P egl-1 gfp reporter accurately portrays the wild-type pattern of egl-1/ BH3 expression.
To identify genes that determine the egl-1/BH3 expression pattern, we screened transcription factors with RNAi phenotypes of sterility or lethality (60 total) from the published genome-wide RNAi screen datasets (Kamath et al., 2003) , reasoning that such genes might have been missed in conventional mutagenesis screens, which generally have not been designed to recover lethal or sterile alleles. As RNAi has a spectrum of gene inactivation in a population of animals, allowing the survival of animals that escape complete inactivation, it can be used to identify and analyze the consequences of partial loss of gene function. Control unc-22(RNAi) did not alter the wild-type pattern of egl-1/BH3 expression, but unc-62/Meis(RNAi) resulted in ectopic (Sulston and Horvitz, 1977) . (D) Lineages of the P5 and P6 cells of five N2 animals exposed to unc-62/Meis(RNAi). Cells that underwent programmed cell death are indicated by an X and highlighted by arrows. unc-62(RNAi) is lethal; we followed lineages in the escapers. (E) DIC image of an animal in which both P5.aap and P6.aap died. Arrows highlight the two corpses. expression of P egl-1 gfp in the midbody region of the ventral nerve cord (Fig. 2B, Table 1B ). The partial loss-of-function alleles unc-62(e917) and unc-62(t2012) also result in ectopic egl-1/BH3 expression in the midbody (Table 1B) . Mutants completely lacking unc-62/Meis gene function exhibit complete embryonic lethality and therefore could not be examined (Van Auken et al., 2002) .
unc-62/Meis ensures survival of the VC motor neurons
To determine whether ectopic egl-1/BH3 transcription resulted in the death of cells that normally survive, we used the ced-1(e1735) background. Control unc-22(RNAi) does not alter the normal pattern of programmed cell deaths, but unc-62/Meis(RNAi) results in ectopic corpses in the midbody region of the ventral nerve cord (Table 1A , Supplemental Fig. 2 ). This phenotype is also observed in unc-62(e917) and unc-62(t2012) mutants ( Supplemental Figs. 2C, D) . We observed the lineages of the P5 and P6 blast cells in five unc-62/Meis(RNAi) animals to determine which cells require unc-62/Meis for survival, and found that four of ten Pn.aap cells died (Figs. 2C-E) . In wild-type animals, the Pn.aap cells invariably survive and differentiate into VC motor neurons (Sulston, 1976) . Therefore, unc-62/Meis, like lin-59/ Ash1 and lin-39/Hox, is required for survival of the VC neurons.
lin-39/Hox and ceh-20/Pbx promote VC survival through transcriptional repression of egl-1/BH3
Previous work has shown that survival of the VC neurons requires the Hox gene lin-39 and the Hox cofactor ceh-20/Pbx, which act upstream of egl-1/BH3 through unknown mechanisms (Clark et al., 1993; Liu et al., 2006) . Because homologs of UNC-62/Meis interact genetically and biochemically with Pbx and Hox homologs (Moens and Selleri, 2006) , we considered the possibility that lin-39/Hox, ceh-20/Pbx, and unc-62/Meis act together to repress egl-1/BH3 and prevent death of the VC neurons. Indeed, reduction of lin-39/Hox or ceh-20/Pbx function by RNAi or mutation results in ectopic P egl-1 gfp expression in the VC neurons ( Fig. 2B ; Table 1B ), suggesting that like unc-62/Meis, lin-39/Hox and ceh-20/Pbx promote VC survival by repressing egl-1/BH3 transcription.
lin-39/Hox likely acts cell-autonomously to prevent death of the VC neurons
If LIN-39/Hox, CEH-20/Pbx, and UNC-62/Meis directly bind egl-1/BH3 to repress transcription in the VC neurons, then all three proteins should be expressed there and function in a cell-autonomous fashion. LIN-39/Hox is present in neurons in the midbody region of the ventral nerve cord (Maloof and Kenyon, 1998; Wagmaister et al., 2006) , and rescuing transgenic reporter constructs suggest that ceh-20/Pbx and unc-62/Meis are broadly expressed in all nuclei in the ventral nerve cord, including the VC neurons (Liu et al., 2006; Yang et al., 2005) (Supplemental Fig. 3 ). Because each of these genes is expressed in the VC neurons and other cells, we considered the possibility that they may act nonautonomously to prevent VC death, for example by affecting the fates of other ventral nerve cord motor neurons. lin-39 mutants crawl normally, however, suggesting that the VA and VB motor neurons, which are required for backwards and forwards movement, are not obviously abnormal. We also examined expression of two markers of VA and VB fate, P unc-4 gfp and P del-1 gfp. Both markers were expressed normally in P unc-4 gfp and P del-1 gfp transgenic animals in which lin-39 was inactivated by RNAi. Specifically, we counted 10.7 fluorescent neurons in the ventral nerve cord of L2 stage P unc-4 gfp; lin-39(RNAi) animals compared to 10.6 fluorescent neurons in control P unc-4 gfp; unc-22(RNAi) animals. Similarly, we counted 14.9 fluorescent neurons in the ventral nerve cord of L2 stage P del-1 gfp; lin-39(RNAi) animals compared to 14.6 fluorescent neurons in control P del-1 gfp; unc-22(RNAi) animals. These data suggest that the fates of the VA and VB neurons are not obviously altered in the absence of lin-39. To directly ask whether targeting lin-39/Hox expression specifically to the VC neurons can prevent VC death, we introduced a P egl-1 lin-39 transgene into ced-1; lin-39 mutants and counted cell corpses in the ventral nerve cord (Fig. 3A) . Indeed, four independent transgenic lines showed similar levels of rescue in the midbody (Supplemental Fig. 4, Fig. 3C ). Because endogenous LIN-39/Hox is limited to the midbody region (Maloof and Kenyon, 1998; Wagmaister et al., 2006 ) and the egl-1/ BH3 promoter is expressed only in the VC neurons of the ventral nerve cord in this region in lin-39/Hox mutants (Fig. 2B and Table  1B ), these data suggest that lin-39/Hox acts cell-autonomously to ensure survival of the VC neurons.
A LIN-39/Hox-CEH-20/Pbx complex ensures VC survival LIN-39/Hox contains a conserved hexapeptide motif N-terminal to the homeodomain (Clark et al., 1993) , which in homologous proteins is required for binding to the Pbx cofactor but not for DNA binding or protein stability in vitro or in vivo (Chang et al., 1995; Knoepfler and Kamps, 1995; Neuteboom et al., 1995; Phelan and Featherstone, 1997; Phelan et al., 1995) . We created two LIN-39/Hox mutant proteins in which the critical tryptophan of the hexapeptide was mutated, LIN-39/Hox(W N F) and LIN-39/Hox(WM N AA), expressed and purified these proteins from E. coli, and tested their function in an electrophoretic mobility shift assay (EMSA). Wild-type LIN-39/Hox efficiently bound a consensus Hox-Pbx probe and cooperated with CEH-20/Pbx in a dose-dependent manner (Fig. 3B, lanes 1-4) . As expected, both mutant proteins bound DNA as well as wild-type, but failed to cooperate with CEH-20/Pbx (Fig. 3B, lanes 5-10) .
We used the lin-39/Hox in vivo rescue assay described above to determine whether these mutant proteins were able to prevent death of the VC neurons. We found that although expression of wild-type lin-39/Hox(+) cDNA in the VC neurons rescued their death, lin-39/ Hox(W N F) or lin-39/Hox(WM N AA) cDNA did not (Fig. 3C , Supplemental Fig. 4) . This suggests that a LIN-39/Hox-CEH-20/Pbx complex represses egl-1/BH3 transcription to ensure VC neuron survival.
LIN-39/Hox likely acts as a transcriptional repressor to prevent cell death
Hox proteins can function as transcriptional activators or repressors (Moens and Selleri, 2006) . To determine whether lin-39 acts as a repressor or activator to prevent cell death, we fused lin-39/Hox coding sequences to the activation domain of VP16 or the repression domain of Engrailed (Jaynes and O'Farrell, 1991; Sze et al., 1997) and tested these fusion constructs using the rescue assay described above. Engrailed:LIN-39 promoted VC survival much more efficiently than VP16:LIN-39, suggesting that LIN-39/Hox functions as a transcriptional repressor to prevent death of the VC neurons in wild-type animals (Fig. 3D, Supplemental Fig. 4 ). This finding is consistent with direct repression of egl-1/BH3 transcription by a LIN-39/Hox-CEH-20/Pbx complex in the VC neurons.
Ectopic lin-39/Hox expression can prevent programmed cell death
The rescue assay used above drives lin-39/Hox expression in all cells that express egl-1/BH3, including cells outside the midbody region to which lin-39/Hox expression is normally restricted (Wagmaister et al., 2006; Wang et al., 1993) . In the posterior region of the ventral nerve cord (P9-P12 descendants), seven cells undergo programmed cell death in wild-type animals, and approximately six corpses are observed in both ced-1 and ced-1; lin-39 mutants (Fig. 3C ) (Clark et al., 1993) . Remarkably, expression of P egl-1 lin-39 or P egl-1 Engrailed:lin-39 suppressed programmed cell death in the posterior ventral cord (Fig. 3D) . This implies that ectopic expression of LIN-39/Hox in cells that normally die in wild-type animals can repress egl-1/BH3 through cooperation with CEH-20/Pbx, blocking an intrinsic mechanism for programmed cell death that normally kills these cells.
egl-1/BH3 repression in the VC neurons requires multiple redundant sites
The results described would be consistent with direct repression of egl-1/BH3 transcription by a LIN-39/Hox-CEH-20/Pbx complex in the VC neurons. If this hypothesis were correct, we would expect to find one or more Hox/Pbx consensus sites in the promoter of egl-1/BH3 that are required for repression in the VCs. The minimal fragment of the egl-1/ BH3 genomic locus required for rescue of the correct cell death pattern in the ventral nerve cord of egl-1/BH3 mutant animals is 7.66 Kb long, with the majority of the regulatory region lying 3′ to the egl-1/BH3 open reading frame (Fig. 4A) (Liu et al., 2006) . A search for consensus Hox/ Pbx binding sites in the promoter identifies 116 matches, of which 12 are conserved between C. elegans, C. remaneii, and C. briggsae, three distantly related nematode species. The locations of the 12 conserved sites are indicated by asterisks in Fig. 4A . We disrupted all 12 conserved sites by site-directed mutagenesis in a single P egl-1 gfp construct. The resulting construct was correctly repressed in the VC neurons (data not shown), suggesting that either LIN-39/CEH-20 represses egl-1/BH3 indirectly through non-Hox consensus binding sequences, or it binds one or more of the remaining 104 sites.
To attempt to identify a single region of egl-1/BH3 that is required for repression in the VCs, whether bound by a LIN-39/Hox-CEH-20/ Pbx complex or by another hypothetical transcription factor, we made a series of six deletion mutants that systematically removed 1 kb segments of egl-1/BH3 sequence, covering the entire noncoding region of egl-1/BH3. Each of these deletion mutants was correctly repressed in the VC neurons, suggesting that the factor or factors that repress egl-1/BH3 in the VC neurons bind and act through multiple, dispersed and redundant sites (data not shown).
LIN-39/Hox and CEH-20/Pbx bind the egl-1/BH3 locus at multiple sites in vivo
We used chromatin immunoprecipitation (ChIP) to determine whether LIN-39/Hox, CEH-20/Pbx, and UNC-62/Meis were enriched at the egl-1/BH3 genomic locus in vivo. We performed immunoprecipitation of protein-cross-linked-DNA from the P lin-39 lin-39:gfp strain (Wagmaister et al., 2006) with anti-All Fluorescent Protein (anti-AFP) antibody or IgG control and used quantitative PCR to compare the amount of egl-1/BH3 DNA bound to each. Primers designed toward widely separated regions of egl-1/BH3 showed weak but reproducible enrichment, suggesting that LIN-39/Hox binds to egl-1/BH3 at multiple, dispersed sites (Fig. 4B) . Primers designed toward a control genetic locus not known to be regulated by Hox genes did not show reproducible enrichment, suggesting that the immunoprecipitation specifically brought down DNA associated with the LIN-39:GFP fusion protein. ChIP experiments using the same antibody were performed with the P ceh-20 ceh-20:yfp and P unc-62 unc-62:cfp rescuing translational fusions to examine CEH-20/Pbx and UNC-62/Meis association with the egl-1/BH3 locus. We observed reproducible enrichment of CEH-20/Pbx, but not UNC-62/Meis, at several sites along the egl-1/BH3 promoter (Figs. 4C, D) . These results, taken together with those described above, suggest that a complex composed of LIN-39/Hox and CEH-20/Pbx binds the egl-1/BH3 regulatory region at multiple dispersed, redundant sites to repress egl-1/BH3 transcription in the VC neurons.
unc-62/Meis is required for nuclear localization of CEH-20/Pbx
Because we did not observe enrichment of UNC-62/Meis at the egl-1/BH3 locus, we asked whether this protein might be involved in egl-1/BH3 repression in a less direct manner. In Drosophila, the unc-62/ Meis homolog Homothorax is required for nuclear localization of the ceh-20/Pbx homolog Extradenticle (Stevens and Mann, 2007) , and one report in C. elegans suggests the same may be true in this organism as well (Van Auken et al., 2002) . We therefore examined the subcellular localization of CEH-20/Pbx in animals carrying the P ceh-20 ceh-20:yfp reporter. In control unc-22(RNAi) animals, CEH-20/ Pbx was localized in the nuclei of cells where it was expressed, which included the lateral hypodermal cells (Fig. 5B ) and all nuclei of the ventral nerve cord (Fig. 5F ). However, in unc-62/Meis(RNAi) animals, nuclear localization was lost in the lateral hypodermal cells (Fig. 5D) and was absent or variable in many neuronal nuclei in the ventral nerve cord (Fig. 5H) . The discrepancy in severity of the defect in nuclear localization we observed between hypodermal cells and neurons may be due to reduced efficiency of RNAi in neuronal cells compared to nonneuronal cells in C. elegans (Simmer et al., 2002) . These data suggest that unc-62/Meis contributes to egl-1/BH3 repression and VC survival by promoting nuclear localization of CEH-20/Pbx.
Further evidence supporting a role for unc-62/Meis in promoting CEH-20/Pbx function comes from analysis of ceh-20/Pbx transcript levels (Fig. 1E) . Surprisingly, ceh-20/Pbx mRNA levels are increased in ceh-20/Pbx partial loss-of-function mutants compared to wildtype controls, suggesting that ceh-20/Pbx transcription is controlled in part by a self-regulatory negative feedback mechanism. The levels of ceh-20/Pbx mRNA are also increased in unc-62/Meis mutants compared to wild-type controls, suggesting that unc-62/Meis is required for proper ceh-20/Pbx function in the context of this negative feedback mechanism.
These data suggest that a complex composed of LIN-39/Hox and CEH-20/Pbx directly binds egl-1/BH3 and represses its transcription. This activity depends on unc-62/Meis for nuclear localization of CEH-20/Pbx, and on lin-59/Ash1 for maintenance of lin-39/Hox mRNA levels. Survival of the VC motor neurons requires the activity of these four genes, and the ultimate mechanism through which they promote cell survival is through Hox-mediated transcriptional repression of the BH3-only gene egl-1.
Discussion
Here we describe the mechanism through which four genes cooperate to prevent programmed cell death of the VC neurons of C. elegans. The Hox transcription factor LIN-39 and the TALE-class cofactor CEH-20/Pbx cooperate to repress egl-1/BH3 transcription and prevent programmed cell death. Two novel regulators of programmed cell death, the trithorax-group gene lin-59/Ash1L and the TALE-class cofactor unc-62/Meis, promote cell survival by maintaining lin-39/Hox transcript levels and facilitating nuclear localization of CEH-20/Pbx, respectively. Loss of any of these four genes results in egl-1/BH3 expression and programmed cell death. Our data are consistent with direct repression of egl-1/BH3 transcription by a LIN-39/Hox-CEH-20/Pbx complex, but do not show this conclusively. Our ChIP data suggest that CEH-20/Pbx and likely LIN-39/Hox can bind egl-1 in vivo. However, because ChIP in C. elegans surveys chromatin binding in whole animals it cannot distinguish whether this complex forms on egl-1/BH3 in the VC neurons or in other cells.
Hox-mediated inhibition of programmed cell death in the VC neurons contrasts with previous work identifying a distinct Hox-Pbx complex that promotes programmed cell death of a different cell, P11. aaap (Liu et al., 2006) . In P11.aaap, the more posterior Hox protein MAB-5 binds the egl-1/BH3 promoter cooperatively with CEH-20/Pbx to activate transcription, resulting in cell death. In the absence of MAB-5 or CEH-20, or with mutations in egl-1/BH3 regulatory DNA sequences that prevent DNA binding by the MAB-5/CEH-20 complex, egl-1/BH3 is not expressed and P11.aaap survives. It is not clear how two distinct Hox-Pbx heterodimers, LIN-39-CEH-20 in the VC neurons and MAB-5-CEH-20 in P11.aaap, exert opposite effects on egl-1/BH3 transcription. lin-39/Hox is active in the midbody and mab-5/Hox in the posterior. The transcriptional outcome could be determined solely by which Hox protein is expressed and incorporated into the heterodimer. Alternatively, the Hox proteins could be functionally interchangeable and directly recruit transcriptional coactivators and corepressors that are active in the different cells, or could recruit these factors indirectly through other cell type-specific factors with which the Hox protein complexes interact. We observed that expression of LIN-39/Hox outside its normal domain is sufficient to prevent programmed cell death in some cells, suggesting that it can engage a mechanism in posterior cells that blocks cell death; this mechanism also requires interaction with CEH-20/Pbx. In contrast, ectopic expression of MAB-5/Hox does not affect the pattern of programmed cell death (Salser et al., 1993) , suggesting that repression of cell death by LIN-39/Hox and promotion of cell death by MAB-5/Hox in part reflects intrinsic differences in the functional interactions mediated by the specific Hox proteins with other cell type-specific factors.
Hox, Pbx, Meis, and Trithorax-group proteins cooperate to induce acute myelogenous and acute lymphoblastic leukemia in humans and mouse models through mechanisms that are not yet well understood, as recently reviewed (Sitwala et al., 2008) . Published work describing the mechanisms that decide whether individual cells of C. elegans survive or undergo programmed cell death have revealed a remarkable correlation between regulators of cell death in C. elegans and human oncogenesis. Seven of the nine genes previously identified that directly regulate the cell death decision are C. elegans homologs of human oncogenes, and here we extend this by identifying unc-62/ Meis, the homolog of which is an essential cofactor in many human leukemias (Sitwala et al., 2008; Wong et al., 2007) . The human ortholog of lin-59, Ash1L, is not clearly an oncogene in leukemias, but shares with MLL the essential function of histone H3K4 modification to promote Hox gene expression (Chamberlin and Thomas, 2000; Milne et al., 2002; Nakamura et al., 2002) . The correlation between genes that regulate cell survival in C. elegans and those that act as human oncogenes suggests that transcriptional repression of apoptosis may be an essential function of oncogenic transcription factors that has been selected for in cancers. Moreover, we suggest that the mechanism we describe here, in which a trithorax-group protein acts through a Hox complex to ensure survival of specific cells, is a model for one aspect of how Hox overexpression promotes leukemia. Specifically, activation of Hox complex activity may promote leukemia in part through transcriptional repression of a BH3-only gene, preventing apoptosis of abnormal hematopoietic or leukemic cells. In support of this idea, mice with mutations affecting BH3-only genes develop hematological malignancies, suggesting that abnormal repression of BH3-only gene expression could promote leukemogenesis (Egle et al., 2004; Ranger et al., 2003; Zinkel et al., 2003) .
The mechanisms through which Hox complex activation results in leukemia are well studied but important questions remain. Fusions involving the trithorax-group gene MLL result in overexpression of several Hox genes and cofactors and cause leukemia, but which Hox targets have causative roles in this process, and a mechanistic understanding of those roles, are poorly understood (Argiropoulos et al., 2007; Armstrong et al., 2002; Ayton and Cleary, 2003; Kumar et al., 2004; Wong et al., 2007) . Concurrent overexpression of HoxA9 and Meis1 is sufficient to cause leukemia in mouse models (Kroon et al., 1998) , and overexpression of HoxA9 and Meis1 are poor prognostic indicators in human leukemia (Afonja et al., 2000; Golub et al., 1999; Serrano et al., 2006) . Although Meis1 is required for MLL fusioninduced leukemia in mouse models, HoxA9 may not be, probably because of redundancy with other Hox proteins (So et al., 2004) . Until recently, Pbx proteins were not thought to be essential; however, recent experiments show that concurrent depletion of Pbx2 and Pbx3 results in the inability of MLL fusions to cause leukemia (Wong et al., 2007) . How Hox, Pbx, and Meis proteins collaborate to induce leukemia is not known (Sitwala et al., 2008) . Because leukemia cells express many Hox, Pbx and Meis cofactor genes with at least some redundant functions, loss-of-function approaches to assess the role of individual genes are problematic. The relative simplicity of the Hox complex in C. elegans, with six genes (Aboobaker and Blaxter, 2003) , and a single Pbx family member with a role in programmed cell death in the ventral nerve cord (Liu et al., 2006) , made it possible for us to define a mechanism of regulation of a single target gene that controls a process, programmed cell death, important in oncogenesis.
To develop improved therapies the molecular mechanisms that maintain the transformed phenotype must be identified; these are likely to be cell type and gene-specific, as we describe here for regulation of egl-1/BH3 in the VC neurons. If Hox protein complexes repress pro-apoptotic BH3-only genes in leukemias, then disruption of this mechanism may induce apoptosis of leukemia cells outright or may sensitize them to other apoptosis-inducing therapies. Strikingly, our results immediately suggest one potential strategy for disrupting Hox-mediated BH3 repression. Disrupting the interaction between LIN-39/Hox and CEH-20/Pbx by mutation of a critical tryptophan was sufficient to prevent the ability of LIN-39 to promote cell survival, both in the VC neurons where LIN-39 is endogenously expressed, and in other cells where ectopic expression of LIN-39 otherwise prevents naturally occurring cell death. Arguably, the latter situation may be analogous to leukemia cells where Hox expression has been artificially elevated through chromosomal translocations or other means.
In conclusion, we have demonstrated that a Hox complex promotes cell survival by repressing transcription of the BH3-only gene egl-1 in the VC neurons of C. elegans. We suggest that activation of Hox complex activity results in transcriptional repression of human BH3-only genes, and that this process may be critical for the survival of this specific subset of leukemia cells. If so, this mechanism may represent a promising new therapeutic target for treatment of these leukemias.
